Your browser doesn't support javascript.
loading
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance.
Bessone, Federica; Dianzani, Chiara; Argenziano, Monica; Cangemi, Luigi; Spagnolo, Rita; Maione, Federica; Giraudo, Enrico; Cavalli, Roberta.
Afiliación
  • Bessone F; Department of Drug Science and Technology, University of Turin, Turin 10125, Italy.
  • Dianzani C; Laboratory of Tumor microenvironment, Candiolo Cancer Institute - FPO, IRCCS, Candiolo 10060, Italy.
  • Argenziano M; Department of Drug Science and Technology, University of Turin, Turin 10125, Italy.
  • Cangemi L; Department of Drug Science and Technology, University of Turin, Turin 10125, Italy.
  • Spagnolo R; Department of Drug Science and Technology, University of Turin, Turin 10125, Italy.
  • Maione F; Department of Drug Science and Technology, University of Turin, Turin 10125, Italy.
  • Giraudo E; Laboratory of Tumor microenvironment, Candiolo Cancer Institute - FPO, IRCCS, Candiolo 10060, Italy.
  • Cavalli R; Department of Drug Science and Technology, University of Turin, Turin 10125, Italy.
Cancer Drug Resist ; 4(1): 192-207, 2021.
Article en En | MEDLINE | ID: mdl-35582009
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Cancer Drug Resist Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Cancer Drug Resist Año: 2021 Tipo del documento: Article País de afiliación: Italia